-
Taxonomy & unit
-
ratio: %
-
Description
-
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
-
Summary
-
PaxMedica, Inc. quarterly Debt-to-equity history and growth rate from Q1 2023 to Q1 2024.
- PaxMedica, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 169 %.
Debt-to-equity, Quarterly (%)